Correction: From Bench to Bedside: ROS-Responsive Nanocarriers in Cancer Therapy

IF 3.4 4区医学 Q2 PHARMACOLOGY & PHARMACY AAPS PharmSciTech Pub Date : 2025-01-13 DOI:10.1208/s12249-024-03036-w

Abhishek Chauhan, Raj Kamal, Rohit Bhatia, Thakur Gurjeet Singh, Ankit Awasthi

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正：从实验室到床边：肿瘤治疗中的ros反应性纳米载体

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

IF 0 Breast diseasePub Date : 2010-01-01 DOI: 10.3233/BD-2010-0314

Jennifer Eng-Wong, Sally Hunsberger, Jo Anne Zujewski

TMEPAI genome editing in triple negative breast cancer cells

IF 0.5 Medical Journal of IndonesiaPub Date : 2017-05-16 DOI: 10.13181/MJI.V26I1.1871

B. W. Wardhani, M. U. Puteri, Yukihide Watanabe, M. Louisa, R. Setiabudy, Mitsuyasu Kato

ADAR1 editing dependency in triple-negative breast cancer

IF 0 bioRxiv : the preprint server for biologyPub Date : 2020-02-02 DOI: 10.1101/2020.01.31.928911

Che-Pei Kung, Kyle A. Cottrell, Sua Ryu, Emily R. Bramel, R. Kladney, Emily A. Bross, L. Maggi, J. Weber

来源期刊

AAPS PharmSciTech 医学-药学

CiteScore

6.80

自引率

3.00%

发文量

264

审稿时长

2.4 months

期刊介绍： AAPS PharmSciTech is a peer-reviewed, online-only journal committed to serving those pharmaceutical scientists and engineers interested in the research, development, and evaluation of pharmaceutical dosage forms and delivery systems, including drugs derived from biotechnology and the manufacturing science pertaining to the commercialization of such dosage forms. Because of its electronic nature, AAPS PharmSciTech aspires to utilize evolving electronic technology to enable faster and diverse mechanisms of information delivery to its readership. Submission of uninvited expert reviews and research articles are welcomed.